Navigation Links
Medbox, Inc. Announces New Product Line for 2012
Date:1/26/2012

HOLLYWOOD, Calif., Jan. 26, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) announced today their new lineup of products for 2012.

Through their subsidiary, Prescription Vending Machines, Inc., the company sells medicine dispensing and storage systems, which are designed to be used in hospitals, pharmacies, urgent care centers, alternative medicine clinics and doctor's offices. The systems maintain inventory control, increase accountability of employees dispensing medicine to consumers, document legal compliance, as well as create an easy method of customer retrieval of prescriptions. The patented systems use biometric fingerprint scans to identify authorized users. The systems also maintain an unalterable and permanent record that provides the utmost in transparency and compliance to local and state laws.

Safe Access Storage Lockers is a patent-pending system that provides a secure method to store, exchange, or sell tangible items. This unique system of 120 individual boxes allows the primary user to assign a code to a secondary user, who can then access the lock box after biometric verification. Thus, transactions can be completed safely, anonymously, and discretely.

The Medbox Rx is a unique system that allows pharmacists to load a customer's medicine into a secure temporary use lockbox for later retrieval. After registering, the customer can return to the pharmacy at their convenience (thus avoiding the lines) and with a swipe of their authorization card and a quick fingerprint recognition scan, a lockbox door opens and they can access their medicine.   

The Medbox™ Rx is the world's first patented prescription dispensing system to feature a biometric fingerprint recognition program to assure patient identity. The system also takes a photograph of each person conducting a transaction and maintains a permanent record of every operati
'/>"/>

SOURCE Medbox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology news :

1. Medbox, Inc. Announces New Board of Directors After Acquisition of Prescription Vending Machines, Inc.
2. Medbox, Inc. Announces Approval in Colorado House Bill (HB1043)
3. NIAID announces 25 new awards to develop radiation countermeasures
4. Aware Announces Q3 2008 Earnings Conference Call
5. Governor Doyle announces historic genomic research collaboration
6. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
7. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
8. Parkinsons Disease Foundation announces award of $150,000
9. Jefferson Department of Surgery announces new pancreas tumor registry
10. NAS announces initiative to connect entertainment industry with top experts
11. Elsevier announces winners of 3rd Annual Scopus Young Indian Scientist Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... durability in fuel cell powered buses, including a ... between electrode degradation processes and bus membrane durability. ... electrode degradation stressors in the operating cycle of ... findings of the study, led by SFU graduate ... long-term study at Burnaby-based Ballard Power Systems and ...
(Date:5/22/2013)... streamlined approach to genetic engineering drastically reduces the ... into bacteria, the workhorses of biotechnology, scientists are ... Biology , the method paves the way for ... development, environmental cleanup and other activities. , Keith ... a piece of the genetic material DNA into ...
(Date:5/22/2013)... details on how climate change will affect interactions between ... Journal of Animal Ecology . This knowledge, they ... policymakers of how species are likely to be impacted ... growing recognition among biologists that climate change is affecting ... is going to have very important consequences for the ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... and streams in remote parts of the UK, southern ... brown by dissolved organic matter. In this weeks Nature ... from UCL (University College London) and the US Environmental ... indicative of a return to a more natural, pre-industrial ...
... Haven, Conn. The gigantic fossil claw of an 390 ... arthropods spiders, insects, crabs and the like were ... scorpion, said O. Erik Tetlie , postdoctoral associate in ... and an author of the report online in Royal Society ...
... being important for the design of nature reserves, assessing ... options for land use. Most present-day analyses suffer from ... closer together in space are more likely to have ... may critically bias model predictions. A new study in ...
Cached Biology News:Don't judge a brook by its color -- brown waters are more natural 2
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan ... human cord blood stem cell banking and therapeutics, announced ... the No. 16 Acorn Stairlifts Indy car driven by ... the remainder of the IZOD IndyCar 2013 season.   ... will work to support awareness of umbilical cord blood ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
... Belgium and LUND, Sweden, February 23 , ... of Partial Factor VIII Inhibition in,Patients Undergoing Knee Replacement ... Brussels: THR) and co-development partner,BioInvent International (OMXS: BINV) announce ... Phase II trial with their long-acting anticoagulant,TB-402 for the ...
... Approval and CommercializationSEATTLE, Feb. 20 Cell Therapeutics, Inc. ... exercised its option to sell its 50% ownership interest ... (Spectrum) for $18 million. CTI and Spectrum established a ... Zevalin. At that time CTI contributed all of the ...
... Feb. 20 Bariatric surgeons at Central,Baptist Hospital made ... procedure to decrease the capacity of a patient,s,stomach without ... the first,incisionless procedure of its kind performed in the ... Peter M. Denk, M.D., performed the procedure, dubbed,POSE (Primary ...
Cached Biology Technology:ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 2ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 3ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 4ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis 5Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 2Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 3Cell Therapeutics Exercises Its Option to Sell Interest in Zevalin Joint Venture to Spectrum Pharmaceuticals for $18 Million 4Surgeons Perform First Incisionless Bariatric Procedure in the United States 2
...
...
... 3501 XL Power Supply, 1. 3500 V, ... current, constant power, and linear voltage ramp ... focused equilibrium in IPG strips quickly without ... for variations in gel thickness, sample ionic ...
Request Info...
Biology Products: